Insider · CIK 0001433982

Zeldis Jerome B

CIK 0001433982 Name as filed on the most recent filing

Filed as Zeldis Jerome B (21)

26 transaction lines · from 21 filings · filed 2013-02-25 to 2024-12-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

26 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-12-02 S, Open-market sale PTC Therapeutics, Inc.PTCT 5 lines 1,235,897, disposed Open Form 4 filing 0001415889-24-028287
2024-11-20 P, Open-market purchase Nexgel, Inc.NXGL 9,999, acquired Open Form 4 filing 0001493152-24-047434
2024-08-23 P, Open-market purchase Nexgel, Inc.NXGL 25,000, acquired Open Form 4 filing 0001493152-24-034094
2024-05-22 S, Open-market sale PTC Therapeutics, Inc.PTCT 764,800, disposed Open Form 4 filing 0001415889-24-014552
2023-05-26 P, Open-market purchase Nexgel, Inc.NXGL 11,689, acquired Open Form 4 filing 0001493152-23-019457
2022-03-25 P, Open-market purchase Nexgel, Inc.NXGL 10,010, acquired Open Form 4 filing 0001104659-22-038736
2021-12-27 P, Open-market purchase Nexgel, Inc.NXGL 49,910, acquired Open Form 4 filing 0001104659-22-000438
2021-05-14 S, Open-market sale Soligenix, Inc.SNGX 2,701, disposed Open Form 4 filing 0001213900-21-027682
2021-05-14 P, Open-market purchase Soligenix, Inc.SNGX 2,664, acquired Open Form 4 filing 0001213900-21-027682
2021-02-17 P, Open-market purchase NexImmune, Inc.NEXI 99,994, acquired Open Form 4 filing 0001209191-21-012366
2020-05-28 P, Open-market purchase BioSig Technologies, Inc.BSGM 10,489, acquired Open Form 4 filing 0001185185-20-000739
2019-11-19 P, Open-market purchase Soligenix, Inc.SNGX 1,850, acquired Open Form 4 filing 0001213900-19-024072
2019-09-19 P, Open-market purchase Soligenix, Inc.SNGX 3,740, acquired Open Form 4 filing 0001213900-19-018664
2019-04-22 P, Open-market purchase Soligenix, Inc.SNGX 7,274, acquired Open Form 4 filing 0001213900-19-006872
2017-04-04 P, Open-market purchase MetaStat, Inc.MTST.OB Not reported Open Form 4 filing 0001415889-17-000625
2017-02-27 P, Open-market purchase Alliqua BioMedical, Inc.ALQA 200,000, acquired Open Form 4 filing 0001144204-17-011952
2017-02-03 P, Open-market purchase Sorrento Therapeutics, Inc.SRNE 51,500, acquired Open Form 4 filing 0000899243-17-002778
2015-12-23 P, Open-market purchase Soligenix, Inc.SNGX 3,175, acquired Open Form 4 filing 0001213900-15-009681
2015-11-06 P, Open-market purchase Alliqua BioMedical, Inc.ALQA 40,740, acquired Open Form 4 filing 0001144204-15-063586
2013-06-28 P, Open-market purchase Alliqua, Inc.ALQA Not reported Open Form 4 filing 0001354488-13-003762
2013-06-25 P, Open-market purchase Soligenix, Inc.SNGX 24,999, acquired Open Form 4 filing 0001213900-13-003308
2013-02-22 P, Open-market purchase Alliqua, Inc.ALQA Not reported Open Form 4 filing 0001354488-13-000857

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 19
  • Open-market sale 7
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. ZELDIS JEROME B, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001433982

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.